Submitted by Anonymous (not verified) on 17 February 2026 - 9:35
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 37, Status: Authorised